• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 36
  • 13
  • 5
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 103
  • 103
  • 14
  • 10
  • 10
  • 9
  • 8
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 6
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
81

Electrophilic androgen receptor ligands as chemotherapeutic agents for prostate cancer

Xu, Huiping 30 September 2004 (has links)
No description available.
82

Effect of the cell-growth rate on the invasion and infection efficacy of Trypanosoma cruzi trypomastigotes, and the potential cell-to-cell transfer of the parasite

Escabia Herrando, Elisa January 2022 (has links)
Recent studies proposed that mammalian cell lines with slower growth rates were infected more efficiently by Trypanosoma cruzi, and that cell-to-cell transmission could be occurring during infection. This open the question of whether host cell-growth rate is a cellular characteristic influencing Trypanosoma cruzi invasion and infection. To prove if this was the case, the cell growth-rate was inhibited by starvation, reducing the foetal bovine serum concentration in the medium, and using a cell-cycle arresting drug, Baicalein. Then the percentage of infected cells of the control and the growth-modified group was measured via epifluorescence microscopy. The results did not show a strong evidence of negative correlation between the cell-growth rate and infection efficacy. To assess if cell-to-cell infection was occurring, the percentage of infected cells in contact with other infected cells was measured. This value was compared to the stochastic probability of this event happening. The results showed that the random probability of an infected cell being next to another infected cell was much lower than the percentage obtained from the empirical data. This suggests that cell-clusters found in infections are not a random event and that the dominant mechanism of infection is a short-range one: either by cell-to-cell infection, or by the proliferation of already infected cells. To support cell-to-cell transmission, parasites potentially passing from one cell to another were inspected through confocal microscopy and actin-rich regions were found at the parasite location. To determine whether actin played a role in this event, cells with a mutation in the actin gene were infected and compared to the mock group. The results showed that the percentage of infected cells in contact with other infected cells was lower for the mutant cells, suggesting that actin could play a key role in this event.
83

Recognition requirements and regulatory events directing T cell responses

Gullberg, Martin January 1983 (has links)
The present study has considered cellular and molecular requirements in T cell responses. The central role of T cell growth factors (TCGF) in T cell responses prompted us to study the regulatory events directing TCGF production in lectin stimulated cultures. It was found that normal spleen cells, activated with Concanavalin A for 24 h, develop suppressive cells that block de novo TCGF production by fresh spleen cells. The induction time for effector suppressor cells (nonadherent, Lyt-2-positive T cells) was found to be 18 h and to parallel the termination of TCGF production in situ. The suppressive mechanism is neither iji situ absorption of TCGF produced at control rates nor killing of TCGF producing cells. These results suggest that suppression of TCGF production is an active process which directly and reversibly blocks TCGF-producing cells. This study also indicated that ConA induced a very limited proliferation of Lyt-2- T helper cells (TH) in unselected T cell populations. The activation and growth requirements of Lyt-1+ TH cells were directly investigated and compared with those of Lyt-2+ cytotoxic T lymphocytes (CTL), as defined by the selective expression of Lyt differentiation antigens and functional activities. This analysis revealed a profound difference in activation and growth requirements between these T cell subsets. Thus, while Lyt-2+ CTL precursors can be induced to TCGF reactivity by soluble lectins, in the absence of specialized accessory cells,; Lyt-2" TH cell precursors show a strict accessory cell requirement both for activation and proliteration. Finally, the low level of TH cell effector function, detected in a primary responses to allo-MHC-antigens or lectins, appears to be due to the development of suppressive Lyt2+ T cells. The functional relevance of Lyt-2 antigens expressed on CTL membranes was further assessed in the last part of this study. Two distinct activation systems were used, namely MHC-antigens, provided as UV-irradiated stimulator cells or polyclonal induction by a 4 h pulse, with lectins. Both procedures were shown to selectively induce Lyt-2+ CTL precursors into TCGF reactivity without leading to mitosis, unless TCGF was added. In both cases it was found that monoclonal anti-Lyt-2 antibodies inhibited the two antigen- dependent phases of CTL responses namely, the initial induction step and target cytolysis. The analogy observed between antigen specific and lectin mediated indueton and target cytolysis, with regard to the susceptibility of inhibition by anti-Lyt-2 antibodies has lead to a general hypothesis on CTL activation. / <p>[4] s., s. 1-58: sammanfattning, s. 59-130, [12] s.: 6 uppsatser</p> / digitalisering@umu
84

Identification d’une nouvelle isoforme du gène suppresseur de tumeur LKB1 ayant des propriétés oncogéniques / Identification of A novel isoform of the tumor suppressor gene LKB1 Having oncogenic properties

Dahmani, Rajae 08 October 2014 (has links)
LKB1 est un gène suppresseur de tumeur qui code une kinase « maitre » dont l’activité contrôle la polarité et la prolifération cellulaire en les coordonnant avec l’état métabolique de la cellule. Ce travail a abouti à l’identification d’une nouvelle isoforme LKB1 appelée ∆N-LKB1 qui est générée par transcription alternative et initiation interne de la traduction de l'ARNm LKB1. La protéine ∆N-LKB1 est délétée de sa partie N-terminale incluant une partie de son domaine kinase. Bien que la protéine N-LKB1 soit catalytiquement inactive, elle potentialise l'effet activateur de la protéine LKB1 sur sa cible principale l’APMK, senseur énergétique de la cellule, via une interaction directe avec le domaine d'auto-inhibition de l’AMPK. En revanche, ∆N-LKB1 interfère négativement avec la capacité de LKB1 à induire la polarité cellulaire. Enfin, en utilisant des approches in vitro et in vivo, nous avons montré que N-LKB1 possède une propriété oncogénique intrinsèque. N-LKB1 est exprimée seule dans la lignée NCI-H460 issue du cancer du poumon. L’inhibition de l’expression de N-LKB1 dans les cellules NCI-H460 induit une diminution de la survie de ces cellules et inhibe leur pouvoir oncogénique quand elles sont greffées dans la souris nude. Nous avons donc identifié une nouvelle isoforme LKB1 qui stimule l’adaptation métabolique LKB1-dépendante, mais qui inhibe la polarité cellulaire contrôlée par LKB1. Le suppresseur de tumeur LKB1 ainsi que l’oncogène N-LKB1 sont codé par le même gène, ce qui peut expliquer certains des effets paradoxaux de LKB1 durant la tumorigenèse. / The LKB1 tumor suppressor gene encodes a master kinase that coordinates the regulation of energetic metabolism, cell growth and cell polarity. We now report the identification of a novel isoform of LKB1 named N-LKB1 that is generated through alternative transcription and internal initiation of translation of the LKB1 mRNA. The N-LKB1 protein lacks the N-terminal region and a portion of the kinase domain. Although N-LKB1 is catalytically inactive, it potentiates the stimulating effect of LKB1 on the AMP-activated protein kinase (AMPK) metabolic sensor through a direct interaction with the regulatory auto-inhibitory domain of AMPK. Contrasting, N-LKB1 negatively interferes with the LKB1 polarizing activity. Finally, combining in vitro and in vivo approaches, we showedthat N-LKB1 has an intrinsic oncogenic property. N-LKB1 is expressed solely in the lung cancer cell line, NCI-H460. Silencing of N-LKB1 decreased survival of NCI-H460 cells and inhibited their tumorigenicity when engrafted in nude mice. In conclusion, we have identified a novel LKB1 isoform that enhances the LKB1-controlled AMPK metabolic activity but inhibits LKB1-induced polarizing activity. Both, the LKB1 tumor suppressor and the oncogene, N-LKB1, are expressed from the same locus and this may account for some of the paradoxical effects of LKB1 during tumorigenesis.
85

The effects of hematopoietic growth factors and tanshinone IIA on neuro-protection. / CUHK electronic theses & dissertations collection

January 2005 (has links)
Neonatal hypoxic-ischemic encephalopathy (HIE) is a common clinical problem. Tanshinone IIA is a compound purified from the Chinese herb Danshen ( Radix Salviae Miltiorrhiza Bge). Thrombopoietin (TPO) and Erythropoietin (Epo) are hematopoietic growth factors. The effects of tanshinone IIA, EPO and TPO on hypoxia-ischemia brain injury were investigated in this study, using in vitro model of neural cell culture and an in vivo model of hypoxic-ischemic brain damage. / Our observation provided the first evidence showing the expression of functional TPO receptor c-mpl in central nervous system. It revealed that novel agents TPO, EPO and tanshinone IIA have neuroprotection effects against brain injury induced by hypoxia-ischemia in neonatal rats, and these agents could be developed for clinical applications. / To investigate the effect of TPO, EPO and tanshinone IIA on in-vivo neural protection, a neonatal rat model of hypoxic-ischemic brain damage was established. Our results demonstrated significant and sustained brain injury in the hypoxic-ischemic and vehicle-treated group, measured by the reduction in relative weights of the ipsilateral (right) to the contralateral (left) brain at 1 and 3 weeks post-surgery, compared with those of sham-operated animals. At 3 weeks post-surgery, the hypoxic-ischemic animals had decreased cortical neuron density quantified by neuron-specific enolase (NSE) staining, and compromised sensorimotor functions in response to the postural reflex test. Treatment with TPO, EPO and tanshinone IIA significantly reduced the severity of brain injury, as indicated by the significantly increased ipsilateral brain weight and neuron density. Recoveries of sensorimotor functions (p &lt; 0.05) and histopathology were also observed in animals that received TPO, EPO and tanshinone IIA. The plasma of tanshinone IIA-treated animals exhibited higher antioxidant activities (oxygen radical absorbance capacity assay) than those from vehicle-treated rats. / TPO and TPO receptor (c-mpl) mRNA was identified in human cerebral hemispheres, cerebellum, mouse neural progenitor cell line C17.2 and four neuroblastoma cell lines (SK-N-MC, MHH-NB-11, SK-N-AS and SH-SY-5Y) using RT-PCR methods. TPO proteins were detected in human cerebrospinal fluid (CSF) and plasma by ELISA. Furthermore, TPO receptor c-mpl was confirmed in human cerebral hemispheres, hippocampus, cerebellum, brainstem and spinal cord using immunohistostaining. TPO had a stimulating effect on the growth of neural progenitor cell C17.2 in culture via the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway as demonstrated by Western blot. The anti-apoptotic effects of TPO, EPO on C17.2 cells were demonstrated by staining with Annexin-V and PI. EPO exerted a protective effect against SHSY-5Y cell damage induced by NMDA (N-methyl-d-aspartate), as demonstrated by the MTT and LDH assay. The anti-oxidative property of tanshinone IIA was studied in the C17.2 cell line. Tanshinone IIA increased the viability of these cells subjected to 2,2'-azobis (2-amidino propane hydrochloride) (AAPH)-induced oxidative stress. / by Xia Wen-Jie. / "May 2005." / Advisers: Kwok-Pui Fung, Tai-Fai Fok. / Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0126. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (p. 126-146). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.
86

Efeitos do tratamento prolongado com isoflavonas de soja no útero, mamas, tecidos adiposo e ósseo de ratas ovariectomizadas / Effects of prolonged treatment with soy isoflavones on the uterus, breast, adipose and bone tissue of ovariectomized rats

Raimunda Ribeiro da Silva 21 March 2013 (has links)
A menopausa, fenômeno fisiológico que ocorre em todas as mulheres, em média, aos 51 anos, é acompanhada em cerca de 80% dos casos de sintomas como fogachos, secura vaginal, irritabilidade e insônia, que interferem na qualidade de vida e na produtividade socioeconômica das mulheres, além de predispô-las a doenças crônico-degenerativas, como arteriosclerose, obesidade e distúrbios cardiovasculares. A terapia de reposição hormonal à base de estrógenos, que visa reduzir os incômodos da menopausa, está associada ao aumento do risco de câncer de mama e do endométrio, como foi demonstrado em estudos científicos. Considerando que as mulheres orientais, consumidoras de soja, apresentam doenças crônico-degenerativas e câncer em taxas inferiores às dos países ocidentais, as isoflavonas da soja têm sido testadas em estudos clínicos e experimentais, porém com obtenção de dados até contraditórios. O presente estudo investigou o efeito da administração crônica de isoflavonas de soja no útero, mamas e tecidos adiposo e ósseo de ratas ovariectomizadas. Quarenta ratas Wistar adultas foram distribuídas em quatro grupos experimentais: a) ovariectomizadas: grupo ISO, recebendo isoflavonas de soja (100mg/kg/dia/v.o.); b) ovariectomizadas: grupo BE, recebendo benzoato de estradiol (10g/kg/dia/s.c.); c) ovariectomizadas: grupo OVX, recebendo salina (0,1ml/100g/dia/v.o.); d) controles: grupo FO, recebendo salina (0,1ml/100g/dia/v.o.). Antes e durante os 90 dias de tratamento, foram analisados os esfregaços vaginais, para acompanhamento do ciclo estral, determinação do peso corporal e do consumo de ração semanal. Após esse período, os animais foram anestesiados e o sangue coletado para análise de estradiol e progesterona séricos, por radioimunoensaio; e lipidograma e glicose, por espectrofotometria. Posteriormente, os animais foram sacrificados e necropsiados, coletando-se o útero, mamas, gordura intra-abdominal e fêmur para macroscopia e pesagem. Os tecidos selecionados para o estudo foram corados em HE, analisados por microscopia óptica e histomorfometria, visando investigar alterações do crescimento celular (software V.S NIH Image-J; imagens digitais-optronicos CCD). No grupo tratado com isoflavonas, o peso corporal diminuiu em relação OVX, no qual ocorreu aumento de peso em comparação aos animais falso-operados. O exame macroscópico revelou que o útero diminuiu de peso nas ratas do grupo ISO, semelhante às do OVX. Além disso, a histopatologia das glândulas endometriais não mostrou alterações entre os grupos ISO e OVX. Contudo, o grupo BE apresentou proliferação glandular, pseudoestratificação epitelial, frequentes mitoses típicas, metaplasia escamosa, infiltrado eosinofílico e hidrométrio. A concentração de estradiol no grupo ISO foi semelhante à do OVX. Porém, no grupo BE, o estradiol e o peso uterino apresentaram-se aumentados em relação ao OVX. Não foram observadas diferenças na histomorfometria mamária entre os grupos. Houve redução no peso do tecido adiposo abdominal no grupo ISO, comparado com o OVX, sem identificação de alterações morfológicas significativas, apenas hipotrofia celular, confirmada pela histomorfometria. Apesar de não ter havido diferenças na concentração de glicose, colesterol total e triglicerídeos, entre os grupos, o colesterol-HDL apresentou aumento no grupo ISO. Não houve diferença na densitometria do fêmur entre os grupos avaliados. Esses resultados indicam que o tratamento crônico com isoflavonas de soja, na dose testada, não induz mudanças significativas no útero, mamas e tecidos adiposo e ósseo, sugerindo segurança no tratamento, sem risco para o desenvolvimento de câncer. / Menopause, physiological phenomenon that occurs in all women, average age 51, is accompanied by about 80% of cases symptoms such as hot flashes, vaginal dryness, irritability and insomnia, which affect the quality of life and socioeconomic productivity women's, and predispose them to chronic degenerative diseases such as atherosclerosis, obesity and cardiovascular disorders. The hormone replacement therapy based on estrogen, which aims to reduce the discomforts of menopause is associated with an increased risk of endometrial and breast cancer, as has been shown in scientific studies. Whereas that women, consuming soy, had lower rates of chronic degenerative diseases and cancer at rates lower than those of Western countries, soy isoflavones have been tested in clinical and experimental studies, but with contradictory results. The present study investigated the effect of chronic administration of soy isoflavones on the uterus, breast, bone and adipose tissues from ovariectomized rats. Forty female Wistar rats were divided into four groups: a) ovariectomized: ISO group receiving soy isoflavones (100mg/kg/dia/vo); b) ovariectomized: EB group receiving estradiol benzoate (10&#956;g/kg/dia/sc); c) ovariectomized: OVX group receiving saline (0.1 ml/100g/dia/vo); d) controls: FO group, receiving saline (0.1 ml/100g/dia/vo). Before and during the 90 days of treatment vaginal smears were analyzed to monitor the estrous cycle, given the body weight and food intake monitored weekly. After this period, the animals were anesthetized and blood was collected for analysis of serum estradiol and progesterone serum by radioimmunoassay, and lipid and glucose by spectrophotometry. Subsequently, the animals were euthanized and necropsied, collecting the uterus, breasts, intra-abdominal fat and femur for macroscopic exam and weighing. The tissues selected for the study were stained with HE and analyzed by light microscopy and histomorphometry, in order to investigated possible changes in cell growth (NIH Image software VS-J;-optronics CCD digital images). In the group treated with isoflavones a decrease in body weight decreased compared OVX in which there was an increase in weight compared to the false-operated animals. Macroscopically, the uterus weight was lower in ISO group, similar to the OVX group. Furthermore, no change was showed in the histopathology of endometrial glands between ISO and OVX groups. The EB group showed glandular proliferation, pseudo-stratified epithelium, frequent mitoses typical squamous metaplasia, and eosinophilic infiltrate and hidrometry. The estradiol concentration in the ISO group was similar to OVX. However, EB group showed increase in estradiol and uterine weight in relation to OVX. No differences in mammary histomorphometry were observed among the four groups. Fat abdominal tissue weight was lower in ISO group compared with OVX group but, no morphological changes were seen on microscopy, only a cellular hipertrophy confirmed by histomorphometry. Although there were no differences in the glucose concentration, total cholesterol and triglycerides among groups, the cholesterol-HDL was increased in the group ISO. There was no difference in femur density among the groups. These results indicate that chronic treatment with soy isoflavones, at the tested dose did not induce significant changes in the uterus, breast, bone and adipose tissues, suggesting safety in handling without risk for development of cancer.
87

Efeitos do tratamento prolongado com isoflavonas de soja no útero, mamas, tecidos adiposo e ósseo de ratas ovariectomizadas / Effects of prolonged treatment with soy isoflavones on the uterus, breast, adipose and bone tissue of ovariectomized rats

Raimunda Ribeiro da Silva 21 March 2013 (has links)
A menopausa, fenômeno fisiológico que ocorre em todas as mulheres, em média, aos 51 anos, é acompanhada em cerca de 80% dos casos de sintomas como fogachos, secura vaginal, irritabilidade e insônia, que interferem na qualidade de vida e na produtividade socioeconômica das mulheres, além de predispô-las a doenças crônico-degenerativas, como arteriosclerose, obesidade e distúrbios cardiovasculares. A terapia de reposição hormonal à base de estrógenos, que visa reduzir os incômodos da menopausa, está associada ao aumento do risco de câncer de mama e do endométrio, como foi demonstrado em estudos científicos. Considerando que as mulheres orientais, consumidoras de soja, apresentam doenças crônico-degenerativas e câncer em taxas inferiores às dos países ocidentais, as isoflavonas da soja têm sido testadas em estudos clínicos e experimentais, porém com obtenção de dados até contraditórios. O presente estudo investigou o efeito da administração crônica de isoflavonas de soja no útero, mamas e tecidos adiposo e ósseo de ratas ovariectomizadas. Quarenta ratas Wistar adultas foram distribuídas em quatro grupos experimentais: a) ovariectomizadas: grupo ISO, recebendo isoflavonas de soja (100mg/kg/dia/v.o.); b) ovariectomizadas: grupo BE, recebendo benzoato de estradiol (10g/kg/dia/s.c.); c) ovariectomizadas: grupo OVX, recebendo salina (0,1ml/100g/dia/v.o.); d) controles: grupo FO, recebendo salina (0,1ml/100g/dia/v.o.). Antes e durante os 90 dias de tratamento, foram analisados os esfregaços vaginais, para acompanhamento do ciclo estral, determinação do peso corporal e do consumo de ração semanal. Após esse período, os animais foram anestesiados e o sangue coletado para análise de estradiol e progesterona séricos, por radioimunoensaio; e lipidograma e glicose, por espectrofotometria. Posteriormente, os animais foram sacrificados e necropsiados, coletando-se o útero, mamas, gordura intra-abdominal e fêmur para macroscopia e pesagem. Os tecidos selecionados para o estudo foram corados em HE, analisados por microscopia óptica e histomorfometria, visando investigar alterações do crescimento celular (software V.S NIH Image-J; imagens digitais-optronicos CCD). No grupo tratado com isoflavonas, o peso corporal diminuiu em relação OVX, no qual ocorreu aumento de peso em comparação aos animais falso-operados. O exame macroscópico revelou que o útero diminuiu de peso nas ratas do grupo ISO, semelhante às do OVX. Além disso, a histopatologia das glândulas endometriais não mostrou alterações entre os grupos ISO e OVX. Contudo, o grupo BE apresentou proliferação glandular, pseudoestratificação epitelial, frequentes mitoses típicas, metaplasia escamosa, infiltrado eosinofílico e hidrométrio. A concentração de estradiol no grupo ISO foi semelhante à do OVX. Porém, no grupo BE, o estradiol e o peso uterino apresentaram-se aumentados em relação ao OVX. Não foram observadas diferenças na histomorfometria mamária entre os grupos. Houve redução no peso do tecido adiposo abdominal no grupo ISO, comparado com o OVX, sem identificação de alterações morfológicas significativas, apenas hipotrofia celular, confirmada pela histomorfometria. Apesar de não ter havido diferenças na concentração de glicose, colesterol total e triglicerídeos, entre os grupos, o colesterol-HDL apresentou aumento no grupo ISO. Não houve diferença na densitometria do fêmur entre os grupos avaliados. Esses resultados indicam que o tratamento crônico com isoflavonas de soja, na dose testada, não induz mudanças significativas no útero, mamas e tecidos adiposo e ósseo, sugerindo segurança no tratamento, sem risco para o desenvolvimento de câncer. / Menopause, physiological phenomenon that occurs in all women, average age 51, is accompanied by about 80% of cases symptoms such as hot flashes, vaginal dryness, irritability and insomnia, which affect the quality of life and socioeconomic productivity women's, and predispose them to chronic degenerative diseases such as atherosclerosis, obesity and cardiovascular disorders. The hormone replacement therapy based on estrogen, which aims to reduce the discomforts of menopause is associated with an increased risk of endometrial and breast cancer, as has been shown in scientific studies. Whereas that women, consuming soy, had lower rates of chronic degenerative diseases and cancer at rates lower than those of Western countries, soy isoflavones have been tested in clinical and experimental studies, but with contradictory results. The present study investigated the effect of chronic administration of soy isoflavones on the uterus, breast, bone and adipose tissues from ovariectomized rats. Forty female Wistar rats were divided into four groups: a) ovariectomized: ISO group receiving soy isoflavones (100mg/kg/dia/vo); b) ovariectomized: EB group receiving estradiol benzoate (10&#956;g/kg/dia/sc); c) ovariectomized: OVX group receiving saline (0.1 ml/100g/dia/vo); d) controls: FO group, receiving saline (0.1 ml/100g/dia/vo). Before and during the 90 days of treatment vaginal smears were analyzed to monitor the estrous cycle, given the body weight and food intake monitored weekly. After this period, the animals were anesthetized and blood was collected for analysis of serum estradiol and progesterone serum by radioimmunoassay, and lipid and glucose by spectrophotometry. Subsequently, the animals were euthanized and necropsied, collecting the uterus, breasts, intra-abdominal fat and femur for macroscopic exam and weighing. The tissues selected for the study were stained with HE and analyzed by light microscopy and histomorphometry, in order to investigated possible changes in cell growth (NIH Image software VS-J;-optronics CCD digital images). In the group treated with isoflavones a decrease in body weight decreased compared OVX in which there was an increase in weight compared to the false-operated animals. Macroscopically, the uterus weight was lower in ISO group, similar to the OVX group. Furthermore, no change was showed in the histopathology of endometrial glands between ISO and OVX groups. The EB group showed glandular proliferation, pseudo-stratified epithelium, frequent mitoses typical squamous metaplasia, and eosinophilic infiltrate and hidrometry. The estradiol concentration in the ISO group was similar to OVX. However, EB group showed increase in estradiol and uterine weight in relation to OVX. No differences in mammary histomorphometry were observed among the four groups. Fat abdominal tissue weight was lower in ISO group compared with OVX group but, no morphological changes were seen on microscopy, only a cellular hipertrophy confirmed by histomorphometry. Although there were no differences in the glucose concentration, total cholesterol and triglycerides among groups, the cholesterol-HDL was increased in the group ISO. There was no difference in femur density among the groups. These results indicate that chronic treatment with soy isoflavones, at the tested dose did not induce significant changes in the uterus, breast, bone and adipose tissues, suggesting safety in handling without risk for development of cancer.
88

Avaliação da expansão de células estromais mesenquimais em biorreator de fibra oca

Santos, Diogo Peres dos 28 February 2013 (has links)
Made available in DSpace on 2016-06-02T19:56:51Z (GMT). No. of bitstreams: 1 5178.pdf: 2466586 bytes, checksum: be50519a129b12383d84e69ae25b54db (MD5) Previous issue date: 2013-02-28 / Universidade Federal de Sao Carlos / The use of mesenchymal stromal cells (MSCs) for clinical therapy has been limited by the low amount of cells that can be obtained directly from tissue, making it necessary to develop techniques for in vitro cell number expansion. The current methods of expansion are laborintensive, exhibit unfavorable environments for cell growth, show still modest levels of expansion and low yield in the recovery of these cells. In the search for better alternatives, several types of bioreactors have been assessed, however, with results still discreet. A littlestudied system, which has showed itself very effective in the use with other types of animal cells, is the hollow fiber bioreactor. This bioreactor has relatively homogeneous culture environment, low level of hydrodynamic stress on cells and the process control is made through manipulation external to the culture. Thus, it is proposed in this work the study of the in vitro expansion of MSCs in 15 mL hollow fiber prototype bioreactor designed and built with a configuration specifically conceived for expansion of MSCs for use in therapeutic applications. The inoculum was prepared with MSCs precultured adhered to microcarrier Cultispher-S at concentration of 4 g/L in spinner flask containing 50 mL of &#945;-MEM culture medium with 15% v/v fetal bovine serum. The preculture was performed in CO2 incubator at pH close to 7.3 and temperature of 37°C. For bioreactor expansion cultures, it was used the same culture medium, with addition of 12 g/L of alginate and 4.25-4.50 mM of CaCl2 as gelling agents to immobilize and keep in suspension the microcarriers, in the conditions of pH and temperature used in the preculture. The oxygenation of the culture medium continuously recirculated through the intracapilar space was carried out by air bubbling in an external flask. The oxygenation levels were of 70 to 90% of saturation with air. The experimental results obtained show that the used configuration of hollow fiber bioreactor promoted good conditions for expansion of MSCs without cell aggregation, reaching 15.3-fold expansion and cell recovery levels of 82%. These results also demonstrate the possibility of improving the efficiency of MSCs expansion through the renewal of medium to maintain suitable levels of arginine, nutrient present in limiting amounts, and ammonium, growth inhibitor metabolite. / A utilização de células estromais mesenquimais (MSCs em inglês) para a terapia clínica tem sido limitada pela baixa quantidade de células que podem ser obtidas diretamente do tecido, tornando necessário o desenvolvimento de técnicas de expansão do número de células in vitro. Os métodos atuais de expansão apresentam necessidade de intensa mão de obra, ambientes desfavoráveis para o crescimento celular, níveis de expansão ainda modestos e baixo rendimento na recuperação destas células. Na procura de melhores alternativas, diversos tipos de biorreatores vêm sendo avaliados, porém, com resultados ainda discretos. Um sistema pouco estudado que tem se mostrado muito eficiente no uso com outros tipos de células animais é o biorreator de fibra oca. Este biorreator apresenta ambiente de cultura relativamente homogêneo, baixo nível de forças hidrodinâmicas sobre as células e o controle do processo é feito através de manipulação externa à cultura. Assim, é proposto neste trabalho o estudo da expansão in vitro de MSCs num protótipo de biorreator de fibra oca de 15 mL projetado e construído com uma configuração especialmente concebida para expansão de MSCs a serem utilizadas em aplicações terapêuticas. O inóculo foi preparado com MSCs précultivadas aderidas ao microcarregador Cultispher-S na concentração de 4 g/L em frasco spinner contendo 50 mL de meio de cultura &#945;-MEM com 15% v/v de soro fetal bovino. O précultivo foi realizado em incubadora de CO2 a pH próximo a 7,3 e temperatura de 37°C. Para os cultivos de expansão no biorreator foi utilizado o mesmo meio de cultura, com adição de 12 g/L de alginato e 4,25-4,50 mM de CaCl2 como agentes geleificantes para imobilizar e manter suspensos os microcarregadores, nas condições de pH e temperatura utilizadas no précultivo. A oxigenação do meio de cultura continuamente recirculado pelo espaço intracapilar foi realizada mediante borbulhamento de ar em um frasco externo. Os níveis de oxigenação foram de 70 a 90% da saturação com ar. Os resultados experimentais obtidos mostram que a configuração utilizada propiciou boas condições para a expansão sem agregação celular das MSCs, chegando-se a fatores de expansão estimados de 15,3 vezes e níveis de recuperação de células de 82%. Esses resultados também evidenciam a possibilidade de melhora da eficiência da expansão das MSCs através da renovação do meio de cultivo para a manutenção de níveis adequados de arginina, nutriente presente em quantidades limitantes, e amônia, metabólito inibidor de crescimento.
89

Estudo de interações proteicas da Tiorredoxina Peroxidase Nuclear (nTPx) de Sacharomyces cerevisiae nos eventos de crescimento celular e silenciamento telomérico

Breyer, Carlos Alexandre 26 August 2011 (has links)
Made available in DSpace on 2016-08-17T18:39:45Z (GMT). No. of bitstreams: 1 4644.pdf: 10384990 bytes, checksum: c8ab8c109d1671b477c700f556bd68bc (MD5) Previous issue date: 2011-08-26 / Universidade Federal de Minas Gerais / The thioredoxin peroxidase (Tpx) is a group of antioxidant proteins that has been widely studied due to its role in the decomposition of different peroxides such as H2O2, peroxynitrite and organic peroxides. The ability of peroxide decomposition by Tpx is related to the presence of a conserved cysteine called peroxidatic cysteine (CysP). Most Tpx has a second cysteine (resolving cysteine - CysR) which forms a disulfide with CysP after peroxide decomposition. In addition to the peroxidase activity, some Tpx have molecular chaperone activity and are also involved in signaling of cell growth induced by hydroperoxides. It has been demonstrated that the Tpx cytosolic isoform of Schizosaccharomyces pombe is able to interact directly with MAPK (Sty1) via mixed disulfide, which is stabilized when the CysR is replaced by a serine residue. Saccharomyces cerevisiae have a nuclear isoform of Tpx (nTPx) and review of the literature shows the importance of this protein in maintaining the telomere silencing and decomposition of organic peroxides in the nucleus. Scale proteomic studies using mass spectrometry and two-hybrid indicate the nTPx association with MAP kinases. However, despite its location and participation in biological processes of relevance, works related to nTPx are scarce. Scale proteomics studies reported the physical interaction between nTPx and Mec3, Gts1, Pc1 and Dog2. These proteins are related to cell signaling or maintenance of telomeric silencing. However, no specific studies were performed to confirm these interactions and if they are established by mixed disulfides. This study aimed to evaluate the interactions previously described in the literature between nTPx and Mec3, Pcl1, Dog2 and Gts1 through the expression and purification of these proteins and in vitro evaluation of interactions as well as in vivo tests using two-hybrid. Several efforts were made with different approaches, nevertheless it was impossible overexpression of Mec3, Pcl1, Dog2, indicating a toxic effect of these proteins on the strains used. Furthermore, we found great success in overexpression of nTPx and nTpxC112S (8 mg and 10 mg per liter of cell culture) in Eschericchia coli strain BL21 (DE3) C43. This is the first time that these proteins were expressed in native form. It was also possible to overexpress the Gts1 protein in the same strain. These results could lead for new approaches in future studies in order to determine these threedimensional structures, by methods such as X-ray crystallography or nuclear magnetic resonance (NMR). Finally, the results obtainedusing the technique of two-hybrid yeast confirmed the interaction in vivo among nTPx and Mec3, Gts1, Dog2. However, opposing the results described in the literature, no interaction was detected between nTPx and PCL1, emphasizing the necessity of specific experiments in addition to the large-scale ones. / As tiorredoxinas peroxidases (TPx), constituem um grupo de proteínas antioxidantes que vêm sendo bastante estudadas pela sua atuação na decomposição de diversos tipos peróxidos, como o H2O2, peroxinitritos e peróxidos orgânicos. A capacidade de decomposição de peróxidos pelas TPx está relacionada a presença de uma cisteína conservada denominada de cisteína peroxidásica (CysP). A maioria das TPx possuem uma segunda cisteína (cisteína de resolução - CysR) a qual forma um dissulfeto com CysP após a decomposição de um peróxido. Adicionalmente, à atividade peroxidásica, algumas TPx possuem atividade de chaperona molecular e também estão envolvidas em processos de sinalização de crescimento celular induzidos por hidroperóxidos. Já foi demonstrado que a isoforma citosólica de TPx de Schizosaccharomyces pombe é capaz de interagir diretamente com uma MAPK (Sty1) através da formação de um dissulfeto misto entre as proteínas, que é estabilizado quando a CysR é substituída por um resíduo de serina. Entretanto, nenhuma interação deste tipo foi descrita para outros organismos. Em Saccharomyces cerevisiae ocorre uma isoforma de TPx no núcleo (nTPx) e a revisão da literatura demonstra a relevância desta proteína na manutenção do silenciamento dos telômeros e decomposição de peróxidos orgânicos no núcleo. Estudos em escala proteômica utilizando espectrometria de massa e duplo híbrido indicam a associação de nTPx com MAP quinases, entretanto, apesar de sua localização e participação em processos biológicos de relevância, trabalhos relacionados com nTPx são escassos. Estudos em escala proteômica relataram a interação física entre nTPx e as proteínas Mec3, Gts1, Pcl1 e Dog2 relacionadas a sinalização celular ou manutenção do silenciamento telomérico. No entanto, não foram efetuados estudos pontuais visando confirmar estas interações como também averiguar a possibilidade das interações entre nTPx e as proteínas supracitadas serem estabelecidas através de dissulfetos mistos. Este trabalho teve por objetivo a avaliação de interações previamente descritas na literatura entre nTPx e Mec3, Pcl1 e Dog2 por meio da expressão e purificação destas proteínas e avaliação in vitro de interações como também in vivo através de ensaios de duplo híbrido. Diversos esforços com diferentes abordagens foram efetuados, entretanto não foi possível a superexpressão de Mec3, Pcl1, Dog2, indicando um efeito tóxico destas proteínas sobre as linhagens utilizadas. Por outro lado, obtivemos grande sucesso na superexpressão de nTPx e nTpxC112S (8 mg e 10 mg por litro de cultura de células) em linhagens de Eschericchia coli BL21 (DE3) C43, o que representa a primeira vez que estas proteínas foram expressas sem trucamentos. Também foi possível expressar na mesma linhagem a proteína Gts1. Estes resultados abrem a possibilidade de estudos posteriores visando a determinação de suas estruturas tridimensionais, por metodologias como cristalografia de raios-X ou ressonância magnética nuclear (RMN). Por fim, os resultados de interação in vivo utilizando a técnica de duplo híbrido em levedura, confirmaram a interação entre nTPx e Mec3, Gts1 e Dog2. Entretanto ao contrario dos resultados descritos na literatura, não foi detectada interação entre nTPx e Pcl1, reforçando que experimentos pontuais são necessários em adição aos experimentos de larga escala.
90

Controlling Depth of Cellular Quiescence by an Rb-E2F Network Switch

Kwon, Jungeun Sarah, Everetts, Nicholas J., Wang, Xia, Wang, Weikang, Della Croce, Kimiko, Xing, Jianhua, Yao, Guang 09 1900 (has links)
Quiescence is a non-proliferative cellular state that is critical to tissue repair and regeneration. Although often described as the G0 phase, quiescence is not a single homogeneous state. As cells remain quiescent for longer durations, they move progressively deeper and display a reduced sensitivity to growth signals. Deep quiescent cells, unlike senescent cells, can still re-enter the cell cycle under physiological conditions. Mechanisms controlling quiescence depth are poorly understood, representing a currently underappreciated layer of complexity in growth control. Here, we show that the activation threshold of a Retinoblastoma (Rb)-E2F network switch controls quiescence depth. Particularly, deeper quiescent cells feature a higher E2F-switching threshold and exhibit a delayed traverse through the restriction point (R-point). We further show that different components of the Rb-E2F network can be experimentally perturbed, following computer model predictions, to coarse-or fine-tune the E2F-switching threshold and drive cells into varying quiescence depths.

Page generated in 0.2212 seconds